Maya Amitai

Dr. Maya Amitai


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
MAMaya Amitai
Maya Amitai
Alan ApterAlan Apter
Alan Apter
Purpose: The present review summarizes the updated literature on the social aspects of suicidal behavior and prevention in adolescents. Recent findings: The predictive role of psychiatric disorders and past history are well recognized in adolescent suicide, but the role of social and cultural factors is less clear. Studies have focused on the importance of ethnicity, gender, family characteristics, and socioeconomic status. More recently, attention has been addressed to broader social risk factors, such as bullying in adolescents, suicide contagion, sexual orientation, and the popular media. Further empirical evidence is needed to advance our understanding of suicidal youth, develop better assessment tools, and formulate effective prevention and treatment programs. Summary: Suicidal behavior remains an important clinical problem and major cause of death in youth. Social factors may be at least as important as genetics. Advancing our understanding of underlying cultural and sociological issues in youth suicide will help clinicians achieve more efficient prediction, prevention and treatment.

30 January 2015 in Current Treatment Options in Psychiatry
Verified
Journal Article
Closed access
PDF file
MAMaya Amitai
Maya Amitai
ACAlon Chen
Alon Chen
Abraham WeizmanAbraham Weizman
Abraham Weizman
AAAlan Apter
Alan Apter

1 September 2015 in International Clinical Psychopharmacology
Verified
Journal Article
Closed access
MAMaya Amitai
Maya Amitai
ESEphi Sachs
Ephi Sachs
AZAmir Zivony
Amir Zivony
RRRoei Remez
Roei Remez
RBReut Ben Baruch
Reut Ben Baruch
GZGil Zalsman
Gil Zalsman
The objective of this study was to determine the long-term hematological and biochemical side effects of valproic acid (VPA) in psychiatric adolescent inpatients. A retrospective naturalistic study design was used. Participants were psychiatric inpatients treated with VPA, alone or in combination with other medications. Electronic medical files were reviewed for changes in hematological and biochemical parameters following a course of VPA treatment. One hundred and four adolescents aged 12–18 (mean 15.76±1.58) years fulfilled the study criteria. The mean blood level and duration of VPA treatment were 65.81±22.18 mcg/ml and 98.57±135.94 days, respectively. The mean levels of thyroid-stimulating hormones and triglyceride levels increased significantly from the first to the last measurement. Platelet count decreased significantly following VPA treatment. No correlation was observed between these parameters and age, duration of treatment, or VPA levels. No serious adverse events were reported. Long-term VPA treatment in adolescents with psychiatric disorders is associated with significant increases in triglyceride levels. Moreover, VPA-treated adolescent psychiatric inpatients may be at risk of developing pituitary–thyroid axis dysregulation and decreased platelet count. Therefore, baseline measurement of thyroid functions and metabolic and hematological parameters and monitoring throughout the treatment are recommended.

9 September 2016 in International Journal of Psychiatry in Clinical Practice
Verified
Journal Article
Closed access
RSRoi Sagy
Roi Sagy
MAMaya Amitai
Maya Amitai
Abraham WeizmanAbraham Weizman
Abraham Weizman
DADov Aizenberg
Dov Aizenberg
Objective: To evaluate the correlation between depression, satisfaction with life, and primary healthcare services consumption. Methods: A random sample of primary healthcare clinic patients agreed to complete self-report questionnaires on demographics and physical activity, the Geriatric Depression Scale (GDS), Satisfaction with Life Scale and the Visual Analog Scale for Happiness. Treating physicians completed the Cumulative Illness Rating Scale (CIRS) for each patient. The relationships among psychometric, medical, the number of visits to health maintenance organization (HMO)-physicians during the previous year was assessed. Results: Positive correlation was found between visits to HMO-physicians and depression severity, as assessed by GDS (p = .049), and between visits/year and illness severity, as measured by CIRS (p < .001). Correlation was also found between depression and number of chronic medications used (p = .005). Physical activity correlated inversely with depression severity (p = .014). Gender and income had no impact on frequency of visits to HMO-physicians, depression, or satisfaction with life. Conclusions: The results indicate that there is a correlation between depression and healthcare service consumption, as represented by number of HMO-physician visits and medication use. Thus, early detection of depression, using tools such as GDS, and early initiation of antidepressive treatment may help to lower the burden on the health system.

6 May 2014
Verified
Journal Article
Closed access
MAMaya Amitai
Maya Amitai
SKSefi Kronenberg
Sefi Kronenberg
TCTali Cohen
Tali Cohen
AFAmos Frisch
Amos Frisch
Abraham WeizmanAbraham Weizman
Abraham Weizman
Alan ApterAlan Apter
Alan Apter

1 September 2012
Verified
Journal Article
Closed access
MAMaya Amitai
Maya Amitai
YSYonathan Sever
Yonathan Sever
Abraham WeizmanAbraham Weizman
Abraham Weizman
GZGil Zalsman
Gil Zalsman